APPLICATION
ANDA078921
TYPE
ANDA
ORIGINAL APPROVAL
2010-06-28
LATEST ACTION
2025-02-18
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Prescription
Products
ANASTROZOLEPrescription
ANASTROZOLE 1MG · TABLET · ORAL
Approval history
2025-02-18Labeling · Supplement 13 · standardAP
2019-09-05Labeling · Supplement 8 · standardAP
2015-08-13Labeling · Supplement 3 · standardAP
2015-08-13Labeling · Supplement 4 · standardAP
2011-11-14Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.